Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation

NCT03589014

Conditions
Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +20 more
Locations
  • IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, FG, Italy
  • IRCCS Centro Neurolesi "Bonino Pulejo" Messina, ME, Italy
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Mi, Italy
  • Fond. IRCCS Ist. Naz. Neurologico Carlo Besta Milan, MI, Italy
View Trial Details
Completed

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

NCT01583283

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States
View Trial Details
Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

NCT03697629

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

NCT03111992

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Freiburg im Breisgau, Germany
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists South Fort Myers, Florida, United States
  • Woodlands Medical Specialists Pensacola, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 13 locations
View Trial Details

Related conditions